A Phase 3 Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis

Clinical trial NCT06594523 · WITHDRAWN

Trial details

NCT number: NCT06594523
Sponsor: Sagimet Biosciences Inc.
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

MASH NASH Metabolic Dysfunction-associated Steatohepatitis Noncirrhotic Metabolic Dysfunction-associated Steatohepatitis Nonalcoholic Steatohepatitis Nonalcoholic Fatty Liver

Start date: 2025-03-01
Primary completion: 2030-12-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.